Week 3 - Neurological / Cancers Flashcards
(122 cards)
Epilepsy- a group of neurologic diseases marked by _____________________
recurring seizures
2 Types of seizures
Focal
Generalized
Generalized seizures- start over wide areas of _____________ of brain
both sides
Focal seizures- begin in _________________ of the brain in a specific region of the cortex
1 hemisphere
2 types of focal seizures
simple
complex
6 types of generalized seizures
tonic-clonic
absense
myoclonic
tonic
atonic
clonic
Psychogenic seizures
Manifests as a tonic-seizure, but it’s not
Cause: ____________
Rhythmic Jerking Movement (can be mistaken as a seizure)
Dx: EEG (electrical brain malfunctions)
Manifests as a tonic-seizure, but it’s not
Cause: Emotional Abuse
Rhythmic Jerking Movement (can be mistaken as a seizure)
Dx: EEG (electrical brain malfunctions)
Seizures - 4 phases
Prodromal
Aural (early ictal)
Ictal
Post ictal
Seizures- risk factors
___________ disturbances
___________ disorders
Metabolic disturbances
extracranial disorders
Seizures- diagnostics
Labs
CT
MRI
EEG
Labs
CT
MRI
EEG
Seizures- nursing management
ABC, O2
Safeguard from _________
_________ to stop seizures
___________________ - Dilantin, Keppra, Cerebyx, Phenobarbital
ABC, O2
Safeguard from injury
Benzos to stop seizures
Anti-convulsants- Dilantin, Keppra, Cerebyx, Phenobarbital
Seizures- complications
SUDEP
NPE
Todd’s paralysis
Status ___________
SUDEP
NPE
Todd’s paralysis
Status Epilepticus
Parkinson’s disease- chronic, progressve neurodegenerative disorder characterized by:
____________
Rigidity, _________ at rest
Gait disturbance
TRAP
Parkinson’s disease- chronic, progressve neurodegenerative disorder characterized by:
Bradykinesia
Rigidity, tremors at rest
Gait disturbance
TRAP
Parkinson’s disease diagnostics
No specific tests
Dx based on ________
No specific tests
Dx based on Hx, S&S
Parkinson’s disease nursing management
__________ with carbidopa (Sinemet)
SE: Dyskinesia
Levodopo with carbidopa (Sinemet)
SE: Dyskinesia
Multiple Sclerosis (MS)- characterized by segmental ___________________________ of brain and spinal cord
demyelination of nerve fibers
Multiple Sclerosis (MS) diagnostics
_____ - demyelinating lesions
MRI
Multiple Sclerosis (MS) nursing management
No cure
Drug therapy to ___________________
-Immunomodulators B-1a and B-1b, Fingolimod (Gilenya)
-Immunosupresants (Dimethyl fumarate/ Tecfidera)
-Corticosteroids (Methylprednisolone/ Solu-Medrol)
No cure
Drug therapy to slow progression
-Immunomodulators B-1a and B-1b, Fingolimod (Gilenya)
-Immunosupresants (Dimethyl fumarate/ Tecfidera)
-Corticosteroids (Methylprednisolone/ Solu-Medrol)
Myasthenia Gravis- chronic, autoimmune disease characterized by profound ___________________________
muscle weakness and fatiguability
Myasthenia Gravis S&S
Painless muscle ____________
Myasthenia ________
Painless muscle weakness
Myasthenia Crisis
Myasthenia Gravis nursing management
Acetylcholinerase inhibitors
Corticosteroids, IV immunoglobulin, Plasmapheresis, immunosuppresives
MV, thymectomy
Acetylcholinerase inhibitors
Corticosteroids, IV immunoglobulin, Plasmapheresis, immunosuppresives
MV, thymectomy
Chronic Seizure (epilepsy): 2 or more seizures and tendency to have recurrent seizures
Cause: __________
Due to _____________________ reacting abnormally, not metabolic disturbances
2 or more seizures and tendency to have recurrent seizures
Cause: Unknown
Due to electrical circuits reacting abnormally, not metabolic disturbances
Seizures: caused by :
(↓ __________or ↓ __________)
metabolic disturbances
(↓ sodium or ↓ glucose)
2 Types of seizures-
Focal Seizures (Localized)
Generalized Seizures (throughout the whole brain)